Significance of imported hepatitis B virus infections

Conference paper
Part of the Archives of Virology Supplement II book series (ARCHIVES SUPPL, volume 11)


The risk of imported hepatitis B in Germany and comparable European countries seems to be low as long as suitable control measures are taken. These measures include testing for hepatitis B markers of immigrants from highly endemic areas as well as of individuals who stayed for a longer period of time in such regions, information of chronic carriers of hepatitis B virus and vaccination of their contacts, and vaccination of travellers to endemic regions who run an increased risk for contracting hepatitis B as e.g. i.v drug users or sex tourists.


Endemic Area Sexual Contact High Risk Behaviour Chronic Carrier Virus Carrier 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tabor E, Purcell RH, London WT, Gerety RJ (1983) Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Infect Dis 147: 531–534PubMedCrossRefGoogle Scholar
  2. 2.
    Seef LB, Hoofnagle JH (1979) Immunoprophylaxis of viral hepatitis. Gastroenterology 77: 161–182Google Scholar
  3. 3.
    Grady GF, Lee VA, Prince AM, Gitnick GL, Fawaz KA, Vyas GN, Lecitt MD, Senior JR, Galambos JT, Bynum TE, Singleton JW, Clowdus BF, Akdamar K, Aach RD, Winkelman EI, Schiff GM, Hersh T (1978) Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis 138: 625–638PubMedCrossRefGoogle Scholar
  4. 4.
    Werner B, Grady GF (1992) Accidental hepatitis-B-surface-antigen-positive inoculations. Ann Int Med 97: 367–369Google Scholar
  5. 5.
    World Health Organization (1991) Working group on the control of viral hepatitis in Europe. Munich 22–25 April. ICP/OCO 01610650YGoogle Scholar
  6. 6.
    Maass G (1983) Definition der Risikogruppen und Bestimmung von Hepatitis B-Markern vor und nach Impfung. In: Deinhardt F, Spiess H (eds) Impfung gegen Hepatitis B. Die Medizinische Verlagsgesellschaft Marburg, pp 23–29Google Scholar
  7. 7.
    Larouze B, Gaudebout C, Mercier E, Lionsquy G, Dazza MC, Elias M, Gaxotte P, Coulaud JP, Ancelle JP (1987) Infection with hepatitis A and B viruses in French volunteers working in tropical Africa. Am J Epidemiol 126: 31–37PubMedGoogle Scholar
  8. 8.
    Dawson DG, Spivey GH, Korelitz JJ, Schmidt RT (1987) Hepatitis B: risk to expatriates in South East Asia. Br Med J Clin Res 294: 547CrossRefGoogle Scholar
  9. 9.
    Steifen R (1990) Risk of hepatitis B for travellers. Vaccine [Suppl] 8: S31-S32CrossRefGoogle Scholar
  10. 10.
    Steffen R, Rickenbach M, Wilhelm U, Helminger A, Schär M (1987) Health problems after travel to developing countries. J Infect Dis 156: 84–91PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1996

Authors and Affiliations

  • W. Jilg
    • 1
  1. 1.Institut für Medizinische Mikrobiologie und HygieneUniversität RegensburgRegensburgFederal Republic of Germany

Personalised recommendations